CANIGEN MHA2L
CANIGEN MHA2L
Authorised
- Canine distemper virus, strain Lederle VR128, Live
- Canine adenovirus 2, strain Manhattan, Live
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 601895, Inactivated
Product identification
Medicine name:
CANIGEN MHA2L
Active substance:
- Canine distemper virus, strain Lederle VR128, Live
- Canine adenovirus 2, strain Manhattan, Live
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 601895, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine distemper virus, strain Lederle VR128, Live5.00/cell culture infective dose 501.00millilitre(s)
-
Canine adenovirus 2, strain Manhattan, Live6.00/cell culture infective dose 501.00millilitre(s)
-
Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated7330.00/enzyme-linked immunosorbent assay unit1.00millilitre(s)
-
Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 601895, Inactivated6910.00/enzyme-linked immunosorbent assay unit1.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AI01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac Espana S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- (AEMPS)
Authorisation number:
- 3185 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Labelling
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
